Cancer Vaccine Market is expected to grow with a CAGR of 17.5% during the forecast period of 2018 to 2025.
CHAPTER 1. INTRODUCTION 1.1. RESEARCH METHODOLOGY 1.1.1. ERC desk research 1.1.2. ERC data synthesis 1.1.3. Data validation and market feedback 1.1.4. ERC data sources CHAPTER 2. CANCER VACCINE MARKET OVERVIEW 2.1. CANCER VACCINE MARKET INTRODUCTION 2.2. GLOBAL CANCER VACCINE MARKET PRODUCTION AND GROWTH RATE, 2017-2025 2.2.1. Global Cancer Vaccine Production (VOLUME) and Growth Rate (%), (2017-2025) 2.3. GLOBAL CANCER VACCINE MARKET CAPACITY AND GROWTH RATE, 2017-2025 2.3.1. Global Cancer Vaccine Capacity (VOLUME) and Growth Rate (%), (2017-2025) 2.4. GLOBAL CANCER VACCINE MARKET REVENUE AND GROWTH RATE, 2017-2025 2.4.1. Global Cancer Vaccine Market Revenue (Million USD) and Growth Rate (%), (2017-2025) 2.5. GLOBAL CANCER VACCINE MARKET CONSUMPTION AND GROWTH RATE, 2017-2025 2.5.1. Global Cancer Vaccine Consumption (VOLUME) and Growth Rate (%), (2017-2025) 2.6. GLOBAL CANCER VACCINE MARKET PRICE TREND, 2017-2025 2.6.1. Global Cancer Vaccine Market Price Trend and Growth Rate (%), (2017-2025) CHAPTER 3. GLOBAL CANCER VACCINE MARKET BY TYPE, 2017-2025 3.1. THERAPEUTIC CANCER VACCINE 3.2. PREVENTIVE CANCER VACCINE 3.3. GLOBAL CANCER VACCINE MARKET REVENUE BY TYPE, 2017-2025 3.3.1. Global Cancer Vaccine Market Revenue (Million USD) and Share (%) By Type, 2017-2025 3.3.2. Therapeutic Cancer Vaccine Market Revenue and Growth Rate, 2017-2025 3.3.3. Preventive Cancer vaccine Market Revenue and Growth Rate, 2017-2025 3.4. GLOBAL CANCER VACCINE MARKET PRODUCTION BY TYPE, 2017-2025 3.4.1. Global Cancer Vaccine Market Production (Volume) and Share (%) By Type, 2017-2025 3.4.2. Therapeutic Cancer Vaccine Market Production and Growth Rate, 2017-2025 3.4.3. Preventive Cancer vaccine Market Production and Growth Rate, 2017-2025 Note: Similar information coverage has been provided for Indication segment. CHAPTER 4. GLOBAL CANCER VACCINE MARKET BY END-USER, 2017-2025 4.1. PEDIATRIC CANCER VACCINE 4.2. ADULT CANCER VACCINE 4.3. GLOBAL CANCER VACCINE MARKET REVENUE BY END-USER, 2017-2025 4.3.1. Global Cancer Vaccine Market Revenue (Million USD) and Share (%) By End-user, 2017-2025 4.3.2. Pediatric Cancer Vaccine Market Revenue and Growth Rate, 2017-2025 4.3.3. Adult Cancer Vaccine Market Revenue and Growth Rate, 2017-2025 4.4. GLOBAL CANCER VACCINE MARKET CONSUMPTION BY END-USER, 2017-2025 4.4.1. Global Cancer Vaccine Market Consumption (Volume) and share (%) By End-user, 2017-2025 4.4.2. Pediatric Cancer Vaccine Market Consumption and Growth Rate, 2017-2025 4.4.3. Adult Cancer Vaccine Market Consumption and Growth Rate, 2017-2025 CHAPTER 5. GLOBAL CANCER VACCINE MARKET BY REGION, 2017-2025 5.1. NORTH AMERICA 5.1.1. U.S. 5.1.2. Canada 5.1.3. Mexico 5.2. EUROPE 5.2.1. U.K. 5.2.2. France 5.2.3. Germany 5.2.4. Italy 5.2.5. Spain 5.2.6. Rest of Europe 5.3. ASIA PACIFIC 5.3.1. China 5.3.2. Japan 5.3.3. India 5.3.4. Korea 5.3.5. Rest of APAC 5.4. SOUTH AMERICA 5.4.1. Brazil 5.4.2. Rest of South America 5.5. REST OF THE WORLD 5.5.1. Middle East 5.5.2. Africa 5.6. GLOBAL CANCER VACCINE MARKET REVENUE BY REGION, 2017-2025 5.6.1. Global Cancer Vaccine Market Revenue (Million USD) and Share (%) By Region, 2017-2025 5.6.2. North America Market Revenue and Growth Rate, 2017-2025 5.6.3. Europe Market Revenue and Growth Rate, 2017-2025 5.6.4. Asia Pacific Market Revenue and Growth Rate, 2017-2025 5.6.5. South America Market Revenue and Growth Rate, 2017-2025 5.6.6. Rest of the World Market Revenue and Growth Rate, 2017-2025 CHAPTER 6. GLOBAL CANCER VACCINE MARKET PRODUCTION AND CONSUMPTION ANALYSIS BY REGION, 2017-2025 6.1. GLOBAL CANCER VACCINE MARKET PRODUCTION ANALYSIS BY REGION, 2017-2025 6.1.1. Global Cancer Vaccine Market Production (Volume) and Share (%) By Region, 2017-2025 6.1.2. Global Cancer Vaccine Market Consumption (Volume) and Share (%) By Region, 2017-2025 6.1.3. North America Market Production and Consumption, 2017-2025 6.1.4. Europe Market Production and Consumption, 2017-2025 6.1.5. Asia Pacific Market Production and Consumption, 2017-2025 6.1.6. South America Market Production and Consumption, 2017-2025 6.1.7. Rest of the World Market Production and Consumption, 2017-2025 CHAPTER 7. MARKET DETERMINANTS 7.1. MARKET DRIVERS 7.2. MARKET RESTRAINTS 7.3. MARKET OPPORTUNITIES 7.4. MARKET DETERMINANTS RADAR CHART CHAPTER 8. GLOBAL CANCER VACCINE MARKET COMPETITION BY MANUFACTURERS 8.1. GLOBAL CANCER VACCINE PRODUCTION AND SHARE BY MANUFACTURERS (2017-2025) 8.1.1. Global Cancer Vaccine Production (VOLUME) and Share (%) by Manufacturers (2017-2025) 8.2. GLOBAL CANCER VACCINE REVENUE AND SHARE BY MANUFACTURERS (2017-2025) 8.2.1. Global Cancer Vaccine Revenue (Million USD) and Share (%) by Manufacturers (2017-2025) 8.3. CANCER VACCINE MARKET COMPETITIVE SITUATION AND TRENDS 8.3.1. Cancer Vaccine Market Share (%) of Top 3 Manufacturers 8.3.2. Cancer Vaccine Market Share (%) of Top 5 Manufacturers CHAPTER 9. GLOBAL CANCER VACCINE MANUFACTURERS ANALYSIS 9.1. ADURO BIOTECH INC. 9.1.1. Business Overview 9.1.2. Company Basic Information 9.1.3. Cancer Vaccine Product Details 9.1.4. Aduro Biotech Inc. Cancer Vaccine Production, Revenue and Gross Margin 9.2. SANPOWER GROUP 9.2.1. Business Overview 9.2.2. Company Basic Information 9.2.3. Cancer Vaccine Product Details 9.2.4. Sanpower Group Cancer Vaccine Production, Revenue and Gross Margin 9.3. SANOFI PASTEUR 9.3.1. Business Overview 9.3.2. Company Basic Information 9.3.3. Cancer Vaccine Product Details 9.3.4. Sanofi Pasteur Cancer Vaccine Production, Revenue and Gross Margin 9.4. PFIZER INC. 9.4.1. Business Overview 9.4.2. Company Basic Information 9.4.3. Cancer Vaccine Product Details 9.4.4. Pfizer Inc. Cancer Vaccine Production, Revenue and Gross Margin 9.5. SERUM INSTITUTE OF INDIA PVT. LTD. 9.5.1. Business Overview 9.5.2. Company Basic Information 9.5.3. Cancer Vaccine Product Details 9.5.4. Serum Institute of India Pvt. Ltd. Cancer Vaccine Production, Revenue and Gross Margin 9.6. GLAXOSMITHKLINE PLC. 9.6.1. Business Overview 9.6.2. Company Basic Information 9.6.3. Cancer Vaccine Product Details 9.6.4. GlaxoSmithKline Plc. Cancer Vaccine Production, Revenue and Gross Margin 9.7. CSL LIMITED 9.7.1. Business Overview 9.7.2. Company Basic Information 9.7.3. Cancer Vaccine Product Details 9.7.4. CSL Limited Cancer Vaccine Production, Revenue and Gross Margin 9.8. MERCK & CO. INC. 9.8.1. Business Overview 9.8.2. Company Basic Information 9.8.3. Cancer Vaccine Product Details 9.8.4. Merck & Co. Inc. Cancer Vaccine Production, Revenue and Gross Margin CHAPTER 10. CANCER VACCINE MARKET VALUE CHAIN ANALYSIS 10.1. CANCER VACCINE INDUSTRIAL CHAIN ANALYSIS 10.2. CANCER VACCINE KEY RAW MATERIALS ANALYSIS 10.2.1. Key Raw Materials 10.2.2. Price Trend of Key Raw Materials 10.2.3. Key Suppliers of Raw Materials 10.3. CONSUMER ANALYSIS 10.3.1. Consumer 1 10.3.2. Consumer 2 10.3.3. Consumer 3 10.3.4. Consumer 4